KR20040021598A

KR20040021598A - Ｕｖｂ-유발 피부손상 방지 방법

Ｕｖｂ-유발 피부손상 방지 방법 Download PDF

Info

Publication number: KR20040021598A
Authority: KR; South Korea
Prior art keywords: tsp; subject; uvb; induced; wrinkles
Prior art date: 2001-04-13
Legal status : Ceased

Application number

KR10-2003-7013393A

Other languages

English (en)

Korean (ko)

Inventor

기이치로 야노

제이. 데트마 마이클

Original Assignee

더 제너럴 하스피탈 코포레이션

Priority date

2001-04-13

Filing date

2002-04-11

Publication date

2004-03-10

2002-04-11 Application filed by 더 제너럴 하스피탈 코포레이션 filed Critical 더 제너럴 하스피탈 코포레이션

2004-03-10 Publication of KR20040021598A publication Critical patent/KR20040021598A/ko

Status Ceased legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 114
230000037380 skin damage Effects 0.000 title description 27
230000037303 wrinkles Effects 0.000 claims abstract description 59
230000007774 longterm Effects 0.000 claims abstract description 47
230000033115 angiogenesis Effects 0.000 claims abstract description 37
108010046722 Thrombospondin 1 Proteins 0.000 claims description 120
101100208237 Bos taurus THBS2 gene Proteins 0.000 claims description 113
239000000203 mixture Substances 0.000 claims description 79
230000000694 effects Effects 0.000 claims description 69
239000003795 chemical substances by application Substances 0.000 claims description 68
239000004037 angiogenesis inhibitor Substances 0.000 claims description 49
229940121369 angiogenesis inhibitor Drugs 0.000 claims description 49
230000001965 increasing effect Effects 0.000 claims description 49
150000001875 compounds Chemical class 0.000 claims description 42
VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 claims description 30
239000002537 cosmetic Substances 0.000 claims description 11
230000002035 prolonged effect Effects 0.000 claims description 10
239000002994 raw material Substances 0.000 claims description 10
239000002870 angiogenesis inducing agent Substances 0.000 claims description 8
230000001939 inductive effect Effects 0.000 claims description 8
239000003205 fragrance Substances 0.000 claims description 7
230000036561 sun exposure Effects 0.000 claims description 7
230000000475 sunscreen effect Effects 0.000 claims description 7
239000000516 sunscreening agent Substances 0.000 claims description 7
230000001225 therapeutic effect Effects 0.000 claims description 7
239000003937 drug carrier Substances 0.000 claims description 6
238000011200 topical administration Methods 0.000 claims description 5
239000008406 cosmetic ingredient Substances 0.000 claims description 4
230000001153 anti-wrinkle effect Effects 0.000 claims description 3
102000007614 Thrombospondin 1 Human genes 0.000 claims 6
230000037330 wrinkle prevention Effects 0.000 claims 5
230000002401 inhibitory effect Effects 0.000 abstract description 13
210000004027 cell Anatomy 0.000 description 174
102100036034 Thrombospondin-1 Human genes 0.000 description 120
108090000623 proteins and genes Proteins 0.000 description 99
108090000765 processed proteins & peptides Proteins 0.000 description 85
210000003491 skin Anatomy 0.000 description 85
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 62
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 62
150000007523 nucleic acids Chemical class 0.000 description 62
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 58
230000014509 gene expression Effects 0.000 description 54
102000004169 proteins and genes Human genes 0.000 description 52
102000004196 processed proteins & peptides Human genes 0.000 description 51
235000018102 proteins Nutrition 0.000 description 50
108020004414 DNA Proteins 0.000 description 49
102000039446 nucleic acids Human genes 0.000 description 49
108020004707 nucleic acids Proteins 0.000 description 49
239000012634 fragment Substances 0.000 description 41
241000699670 Mus sp. Species 0.000 description 38
239000003814 drug Substances 0.000 description 38
150000003384 small molecules Chemical class 0.000 description 30
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 28
229920001184 polypeptide Polymers 0.000 description 28
230000001684 chronic effect Effects 0.000 description 22
108020004999 messenger RNA Proteins 0.000 description 22
108091034117 Oligonucleotide Proteins 0.000 description 20
230000000692 anti-sense effect Effects 0.000 description 20
239000013598 vector Substances 0.000 description 19
241000699660 Mus musculus Species 0.000 description 18
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 18
239000013612 plasmid Substances 0.000 description 18
238000011830 transgenic mouse model Methods 0.000 description 18
241001465754 Metazoa Species 0.000 description 17
150000001413 amino acids Chemical group 0.000 description 17
210000004207 dermis Anatomy 0.000 description 16
108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 15
210000004204 blood vessel Anatomy 0.000 description 15
238000001476 gene delivery Methods 0.000 description 15
230000001105 regulatory effect Effects 0.000 description 15
238000006467 substitution reaction Methods 0.000 description 15
210000001519 tissue Anatomy 0.000 description 15
102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 14
108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 14
238000001727 in vivo Methods 0.000 description 14
238000002703 mutagenesis Methods 0.000 description 14
231100000350 mutagenesis Toxicity 0.000 description 14
230000035772 mutation Effects 0.000 description 14
239000000047 product Substances 0.000 description 14
108020001507 fusion proteins Proteins 0.000 description 13
102000037865 fusion proteins Human genes 0.000 description 13
238000012216 screening Methods 0.000 description 13
238000012360 testing method Methods 0.000 description 13
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 12
108091028043 Nucleic acid sequence Proteins 0.000 description 12
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 12
230000002950 deficient Effects 0.000 description 12
210000002889 endothelial cell Anatomy 0.000 description 12
210000002615 epidermis Anatomy 0.000 description 12
230000004927 fusion Effects 0.000 description 12
238000013518 transcription Methods 0.000 description 12
230000035897 transcription Effects 0.000 description 12
235000001014 amino acid Nutrition 0.000 description 11
230000001772 anti-angiogenic effect Effects 0.000 description 11
230000005764 inhibitory process Effects 0.000 description 11
125000003729 nucleotide group Chemical group 0.000 description 11
239000002245 particle Substances 0.000 description 11
230000005855 radiation Effects 0.000 description 11
241001430294 unidentified retrovirus Species 0.000 description 11
230000037373 wrinkle formation Effects 0.000 description 11
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 10
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 10
230000009368 gene silencing by RNA Effects 0.000 description 10
238000001415 gene therapy Methods 0.000 description 10
239000003446 ligand Substances 0.000 description 10
241000701161 unidentified adenovirus Species 0.000 description 10
102000040650 (ribonucleotides)n+m Human genes 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
241000700605 Viruses Species 0.000 description 9
230000027455 binding Effects 0.000 description 9
230000000295 complement effect Effects 0.000 description 9
239000000499 gel Substances 0.000 description 9
238000000338 in vitro Methods 0.000 description 9
238000002347 injection Methods 0.000 description 9
239000007924 injection Substances 0.000 description 9
239000002773 nucleotide Substances 0.000 description 9
230000002062 proliferating effect Effects 0.000 description 9
108020003175 receptors Proteins 0.000 description 9
238000001890 transfection Methods 0.000 description 9
101150060219 tsp-1 gene Proteins 0.000 description 9
230000004568 DNA-binding Effects 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 description 8
229960005070 ascorbic acid Drugs 0.000 description 8
230000004888 barrier function Effects 0.000 description 8
238000009739 binding Methods 0.000 description 8
230000000875 corresponding effect Effects 0.000 description 8
102000005962 receptors Human genes 0.000 description 8
230000002829 reductive effect Effects 0.000 description 8
239000000243 solution Substances 0.000 description 8
-1 superagonists Substances 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
230000009261 transgenic effect Effects 0.000 description 8
101150007130 tsp-2 gene Proteins 0.000 description 8
230000002792 vascular Effects 0.000 description 8
239000013603 viral vector Substances 0.000 description 8
206010051246 Photodermatosis Diseases 0.000 description 7
230000004075 alteration Effects 0.000 description 7
230000002491 angiogenic effect Effects 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
239000002299 complementary DNA Substances 0.000 description 7
238000012217 deletion Methods 0.000 description 7
230000037430 deletion Effects 0.000 description 7
239000003018 immunosuppressive agent Substances 0.000 description 7
210000002510 keratinocyte Anatomy 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
238000003752 polymerase chain reaction Methods 0.000 description 7
238000007920 subcutaneous administration Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
238000002054 transplantation Methods 0.000 description 7
PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 6
WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 6
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
108091033380 Coding strand Proteins 0.000 description 6
102000008186 Collagen Human genes 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 6
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
239000002211 L-ascorbic acid Substances 0.000 description 6
235000000069 L-ascorbic acid Nutrition 0.000 description 6
YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
210000001744 T-lymphocyte Anatomy 0.000 description 6
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
229930003268 Vitamin C Natural products 0.000 description 6
229930003427 Vitamin E Natural products 0.000 description 6
WYWZRNAHINYAEF-AWEZNQCLSA-N [(2s)-2-ethylhexyl] 4-(dimethylamino)benzoate Chemical compound CCCC[C@H](CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-AWEZNQCLSA-N 0.000 description 6
229940024606 amino acid Drugs 0.000 description 6
229960004050 aminobenzoic acid Drugs 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
230000001186 cumulative effect Effects 0.000 description 6
210000005175 epidermal keratinocyte Anatomy 0.000 description 6
239000000284 extract Substances 0.000 description 6
239000000835 fiber Substances 0.000 description 6
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
229960004881 homosalate Drugs 0.000 description 6
230000003993 interaction Effects 0.000 description 6
239000003550 marker Substances 0.000 description 6
230000001404 mediated effect Effects 0.000 description 6
229960001679 octinoxate Drugs 0.000 description 6
DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 6
229960001173 oxybenzone Drugs 0.000 description 6
229960002638 padimate o Drugs 0.000 description 6
230000008845 photoaging Effects 0.000 description 6
239000000419 plant extract Substances 0.000 description 6
210000002729 polyribosome Anatomy 0.000 description 6
229960003471 retinol Drugs 0.000 description 6
235000020944 retinol Nutrition 0.000 description 6
239000011607 retinol Substances 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
238000010561 standard procedure Methods 0.000 description 6
239000004408 titanium dioxide Substances 0.000 description 6
229960005196 titanium dioxide Drugs 0.000 description 6
229940042585 tocopherol acetate Drugs 0.000 description 6
230000003612 virological effect Effects 0.000 description 6
229940088594 vitamin Drugs 0.000 description 6
229930003231 vitamin Natural products 0.000 description 6
235000013343 vitamin Nutrition 0.000 description 6
239000011782 vitamin Substances 0.000 description 6
235000019155 vitamin A Nutrition 0.000 description 6
239000011719 vitamin A Substances 0.000 description 6
235000019154 vitamin C Nutrition 0.000 description 6
239000011718 vitamin C Substances 0.000 description 6
235000019165 vitamin E Nutrition 0.000 description 6
229940046009 vitamin E Drugs 0.000 description 6
239000011709 vitamin E Substances 0.000 description 6
229940045997 vitamin a Drugs 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
108010001267 Protein Subunits Proteins 0.000 description 5
102000002067 Protein Subunits Human genes 0.000 description 5
108020004459 Small interfering RNA Proteins 0.000 description 5
239000000556 agonist Substances 0.000 description 5
238000000576 coating method Methods 0.000 description 5
238000013270 controlled release Methods 0.000 description 5
230000006378 damage Effects 0.000 description 5
229940079593 drug Drugs 0.000 description 5
230000003511 endothelial effect Effects 0.000 description 5
239000013604 expression vector Substances 0.000 description 5
238000009472 formulation Methods 0.000 description 5
238000007804 gelatin zymography Methods 0.000 description 5
210000004247 hand Anatomy 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
239000002502 liposome Substances 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000002018 overexpression Effects 0.000 description 5
239000008194 pharmaceutical composition Substances 0.000 description 5
238000001556 precipitation Methods 0.000 description 5
230000035755 proliferation Effects 0.000 description 5
230000004044 response Effects 0.000 description 5
239000000523 sample Substances 0.000 description 5
241000894007 species Species 0.000 description 5
238000010186 staining Methods 0.000 description 5
230000006459 vascular development Effects 0.000 description 5
241000702421 Dependoparvovirus Species 0.000 description 4
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 4
101710091045 Envelope protein Proteins 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
241000724791 Filamentous phage Species 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
102000018697 Membrane Proteins Human genes 0.000 description 4
108010052285 Membrane Proteins Proteins 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
101710188315 Protein X Proteins 0.000 description 4
108700019146 Transgenes Proteins 0.000 description 4
108091008605 VEGF receptors Proteins 0.000 description 4
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 4
238000012867 alanine scanning Methods 0.000 description 4
230000008901 benefit Effects 0.000 description 4
210000000038 chest Anatomy 0.000 description 4
239000003085 diluting agent Substances 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
230000002500 effect on skin Effects 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
210000001339 epidermal cell Anatomy 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
230000030279 gene silencing Effects 0.000 description 4
238000003125 immunofluorescent labeling Methods 0.000 description 4
229940125721 immunosuppressive agent Drugs 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
238000007918 intramuscular administration Methods 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
210000003739 neck Anatomy 0.000 description 4
238000002823 phage display Methods 0.000 description 4
239000002904 solvent Substances 0.000 description 4
108091006106 transcriptional activators Proteins 0.000 description 4
230000014616 translation Effects 0.000 description 4
239000003981 vehicle Substances 0.000 description 4
239000000080 wetting agent Substances 0.000 description 4
239000013607 AAV vector Substances 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
241001116389 Aloe Species 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
108091029865 Exogenous DNA Proteins 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
241000282412 Homo Species 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
235000019687 Lamb Nutrition 0.000 description 3
201000004681 Psoriasis Diseases 0.000 description 3
208000028990 Skin injury Diseases 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
241000251539 Vertebrata <Metazoa> Species 0.000 description 3
241000219095 Vitis Species 0.000 description 3
235000009754 Vitis X bourquina Nutrition 0.000 description 3
235000012333 Vitis X labruscana Nutrition 0.000 description 3
235000014787 Vitis vinifera Nutrition 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000004913 activation Effects 0.000 description 3
229940069521 aloe extract Drugs 0.000 description 3
235000011399 aloe vera Nutrition 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
239000000074 antisense oligonucleotide Substances 0.000 description 3
238000012230 antisense oligonucleotides Methods 0.000 description 3
229920000249 biocompatible polymer Polymers 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
239000006071 cream Substances 0.000 description 3
208000018999 crinkle Diseases 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
210000005069 ears Anatomy 0.000 description 3
230000036566 epidermal hyperplasia Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
230000001747 exhibiting effect Effects 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
238000012226 gene silencing method Methods 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
229940038487 grape extract Drugs 0.000 description 3
230000012010 growth Effects 0.000 description 3
210000003128 head Anatomy 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
206010020718 hyperplasia Diseases 0.000 description 3
230000028993 immune response Effects 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000007901 in situ hybridization Methods 0.000 description 3
210000004969 inflammatory cell Anatomy 0.000 description 3
238000011813 knockout mouse model Methods 0.000 description 3
210000004962 mammalian cell Anatomy 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
239000012188 paraffin wax Substances 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
238000002708 random mutagenesis Methods 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
238000007665 sagging Methods 0.000 description 3
230000011664 signaling Effects 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000007910 systemic administration Methods 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
230000024883 vasodilation Effects 0.000 description 3
RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
YSAJFXWTVFGPAX-UHFFFAOYSA-N 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetic acid Chemical compound OC(=O)COC1=CNC(=O)NC1=O YSAJFXWTVFGPAX-UHFFFAOYSA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 2
101150013553 CD40 gene Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102000016942 Elastin Human genes 0.000 description 2
108010014258 Elastin Proteins 0.000 description 2
206010016654 Fibrosis Diseases 0.000 description 2
108010028690 Fish Proteins Proteins 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
108060001084 Luciferase Proteins 0.000 description 2
239000005089 Luciferase Substances 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
102000000424 Matrix Metalloproteinase 2 Human genes 0.000 description 2
108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108010033276 Peptide Fragments Proteins 0.000 description 2
102000007079 Peptide Fragments Human genes 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
102400001320 Transforming growth factor alpha Human genes 0.000 description 2
101800004564 Transforming growth factor alpha Proteins 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000009471 action Effects 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
230000001640 apoptogenic effect Effects 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000037429 base substitution Effects 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000002775 capsule Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000012219 cassette mutagenesis Methods 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000002742 combinatorial mutagenesis Methods 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000000779 depleting effect Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
229920002549 elastin Polymers 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
230000004528 endothelial cell apoptotic process Effects 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000006862 enzymatic digestion Effects 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
230000004761 fibrosis Effects 0.000 description 2
230000009969 flowable effect Effects 0.000 description 2
230000006870 function Effects 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000012744 immunostaining Methods 0.000 description 2
229960003444 immunosuppressant agent Drugs 0.000 description 2
230000006698 induction Effects 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
230000003902 lesion Effects 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000000463 material Substances 0.000 description 2
210000004779 membrane envelope Anatomy 0.000 description 2
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
244000005700 microbiome Species 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
230000014399 negative regulation of angiogenesis Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
238000004091 panning Methods 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
239000008177 pharmaceutical agent Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
230000008832 photodamage Effects 0.000 description 2
238000001126 phototherapy Methods 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
238000007388 punch biopsy Methods 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000008685 targeting Effects 0.000 description 2
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
230000008719 thickening Effects 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
210000003437 trachea Anatomy 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
239000004474 valine Substances 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
HLYBTPMYFWWNJN-UHFFFAOYSA-N 2-(2,4-dioxo-1h-pyrimidin-5-yl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CNC(=O)NC1=O HLYBTPMYFWWNJN-UHFFFAOYSA-N 0.000 description 1
SGAKLDIYNFXTCK-UHFFFAOYSA-N 2-[(2,4-dioxo-1h-pyrimidin-5-yl)methylamino]acetic acid Chemical compound OC(=O)CNCC1=CNC(=O)NC1=O SGAKLDIYNFXTCK-UHFFFAOYSA-N 0.000 description 1
XMSMHKMPBNTBOD-UHFFFAOYSA-N 2-dimethylamino-6-hydroxypurine Chemical compound N1C(N(C)C)=NC(=O)C2=C1N=CN2 XMSMHKMPBNTBOD-UHFFFAOYSA-N 0.000 description 1
SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
KOLPWZCZXAMXKS-UHFFFAOYSA-N 3-methylcytosine Chemical compound CN1C(N)=CC=NC1=O KOLPWZCZXAMXKS-UHFFFAOYSA-N 0.000 description 1
AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 1
GJAKJCICANKRFD-UHFFFAOYSA-N 4-acetyl-4-amino-1,3-dihydropyrimidin-2-one Chemical compound CC(=O)C1(N)NC(=O)NC=C1 GJAKJCICANKRFD-UHFFFAOYSA-N 0.000 description 1
MQJSSLBGAQJNER-UHFFFAOYSA-N 5-(methylaminomethyl)-1h-pyrimidine-2,4-dione Chemical compound CNCC1=CNC(=O)NC1=O MQJSSLBGAQJNER-UHFFFAOYSA-N 0.000 description 1
WPYRHVXCOQLYLY-UHFFFAOYSA-N 5-[(methoxyamino)methyl]-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CONCC1=CNC(=S)NC1=O WPYRHVXCOQLYLY-UHFFFAOYSA-N 0.000 description 1
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
VKLFQTYNHLDMDP-PNHWDRBUSA-N 5-carboxymethylaminomethyl-2-thiouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=S)NC(=O)C(CNCC(O)=O)=C1 VKLFQTYNHLDMDP-PNHWDRBUSA-N 0.000 description 1
ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
KELXHQACBIUYSE-UHFFFAOYSA-N 5-methoxy-1h-pyrimidine-2,4-dione Chemical compound COC1=CNC(=O)NC1=O KELXHQACBIUYSE-UHFFFAOYSA-N 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
102000008076 Angiogenic Proteins Human genes 0.000 description 1
108010074415 Angiogenic Proteins Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
206010006784 Burning sensation Diseases 0.000 description 1
108010045374 CD36 Antigens Proteins 0.000 description 1
108010041884 CD4 Immunoadhesins Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000283707 Capra Species 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
241001503987 Clematis vitalba Species 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
102100032768 Complement receptor type 2 Human genes 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
229930105110 Cyclosporin A Natural products 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
150000008574 D-amino acids Chemical class 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
206010015150 Erythema Diseases 0.000 description 1
238000011771 FVB mouse Methods 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010000916 Fimbriae Proteins Proteins 0.000 description 1
108010040721 Flagellin Proteins 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
101150034617 K14 gene Proteins 0.000 description 1
108010066321 Keratin-14 Proteins 0.000 description 1
208000001126 Keratosis Diseases 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
SGSSKEDGVONRGC-UHFFFAOYSA-N N(2)-methylguanine Chemical compound O=C1NC(NC)=NC2=C1N=CN2 SGSSKEDGVONRGC-UHFFFAOYSA-N 0.000 description 1
206010028851 Necrosis Diseases 0.000 description 1
241000588653 Neisseria Species 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
101710160107 Outer membrane protein A Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
241000009328 Perro Species 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 1
101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 1
108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
101000808006 Rattus norvegicus Vascular endothelial growth factor A Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
108700025701 Retinoblastoma Genes Proteins 0.000 description 1
101800001440 Rimorphin Proteins 0.000 description 1
239000012722 SDS sample buffer Substances 0.000 description 1
238000011804 SKH1 hairless mouse Methods 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
108090000899 Serralysin Proteins 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
206010064127 Solar lentigo Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
206010042496 Sunburn Diseases 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
102100025237 T-cell surface antigen CD2 Human genes 0.000 description 1
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
238000012288 TUNEL assay Methods 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
208000032594 Vascular Remodeling Diseases 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
206010047642 Vitiligo Diseases 0.000 description 1
241000282485 Vulpes vulpes Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
208000009621 actinic keratosis Diseases 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
238000003314 affinity selection Methods 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
231100000360 alopecia Toxicity 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
210000003293 antilymphocyte serum Anatomy 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
150000001538 azepines Chemical class 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
230000003385 bacteriostatic effect Effects 0.000 description 1
210000000270 basal cell Anatomy 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
150000001557 benzodiazepines Chemical class 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Chemical group C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
235000021152 breakfast Nutrition 0.000 description 1
210000000069 breast epithelial cell Anatomy 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
238000002659 cell therapy Methods 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
210000004081 cilia Anatomy 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
230000009194 climbing Effects 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
108010007093 dispase Proteins 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000012636 effector Substances 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000001159 endocytotic effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
231100000321 erythema Toxicity 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
239000011536 extraction buffer Substances 0.000 description 1
210000000744 eyelid Anatomy 0.000 description 1
210000003495 flagella Anatomy 0.000 description 1
239000012530 fluid Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
238000003197 gene knockdown Methods 0.000 description 1
230000037440 gene silencing effect Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
238000012248 genetic selection Methods 0.000 description 1
230000035784 germination Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000003779 hair growth Effects 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000012203 high throughput assay Methods 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
208000000069 hyperpigmentation Diseases 0.000 description 1
230000003810 hyperpigmentation Effects 0.000 description 1
230000002390 hyperplastic effect Effects 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
239000012212 insulator Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
210000002490 intestinal epithelial cell Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000010189 intracellular transport Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
208000014384 isolated congenital growth hormone deficiency Diseases 0.000 description 1
201000002022 isolated growth hormone deficiency Diseases 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000006166 lysate Substances 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
IZAGSTRIDUNNOY-UHFFFAOYSA-N methyl 2-[(2,4-dioxo-1h-pyrimidin-5-yl)oxy]acetate Chemical compound COC(=O)COC1=CNC(=O)NC1=O IZAGSTRIDUNNOY-UHFFFAOYSA-N 0.000 description 1
229960001047 methyl salicylate Drugs 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000036438 mutation frequency Effects 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
XJVXMWNLQRTRGH-UHFFFAOYSA-N n-(3-methylbut-3-enyl)-2-methylsulfanyl-7h-purin-6-amine Chemical compound CSC1=NC(NCCC(C)=C)=C2NC=NC2=N1 XJVXMWNLQRTRGH-UHFFFAOYSA-N 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
239000006218 nasal suppository Substances 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
230000037311 normal skin Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000007968 orange flavor Substances 0.000 description 1
230000008520 organization Effects 0.000 description 1
QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
208000003068 pituitary dwarfism Diseases 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
108010054442 polyalanine Proteins 0.000 description 1
239000008389 polyethoxylated castor oil Substances 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
230000032361 posttranscriptional gene silencing Effects 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
239000003531 protein hydrolysate Substances 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
239000004576 sand Substances 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
210000001732 sebaceous gland Anatomy 0.000 description 1
230000037307 sensitive skin Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000010008 shearing Methods 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
238000007390 skin biopsy Methods 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
230000008470 skin growth Effects 0.000 description 1
206010040882 skin lesion Diseases 0.000 description 1
231100000444 skin lesion Toxicity 0.000 description 1
239000004055 small Interfering RNA Substances 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000013337 sub-cultivation Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
230000002483 superagonistic effect Effects 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
239000008181 tonicity modifier Substances 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000010396 two-hybrid screening Methods 0.000 description 1
108010087967 type I signal peptidase Proteins 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000012762 unpaired Student’s t-test Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000008215 water for injection Substances 0.000 description 1
238000004804 winding Methods 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1
239000008096 xylene Substances 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
238000007805 zymography Methods 0.000 description 1
150000003953 γ-lactams Chemical class 0.000 description 1